Invention Grant
US08663989B2 Retroviral vector particles and methods for their generation and use
有权
逆转录病毒载体颗粒及其产生和使用的方法
- Patent Title: Retroviral vector particles and methods for their generation and use
- Patent Title (中): 逆转录病毒载体颗粒及其产生和使用的方法
-
Application No.: US13511186Application Date: 2010-11-22
-
Publication No.: US08663989B2Publication Date: 2014-03-04
- Inventor: Jörn Stitz
- Applicant: Jörn Stitz
- Applicant Address: CH Basel
- Assignee: 4-Antibody AG
- Current Assignee: 4-Antibody AG
- Current Assignee Address: CH Basel
- Agency: Nevrivy Patent Law Group P.L.L.C.
- Priority: EP09176789 20091123
- International Application: PCT/EP2010/067946 WO 20101122
- International Announcement: WO2011/061336 WO 20110526
- Main IPC: C12N15/86
- IPC: C12N15/86 ; C12N5/02 ; C12N5/00 ; C12P21/06 ; C12P21/04 ; C12N5/07 ; C12N7/00

Abstract:
The present invention relates to methods of host cell transduction utilizing ecotropic retroviral vector particles. The retroviral vector particle may comprise an envelope of Friend murine leukaemia virus, in particular the envelope encoded by molecular clone PVC-211 and the host cell may be engineered to recombinantly express the Reel receptor. The retroviral vector particles and methods of the invention can be used to introduce expressible polynucleotide sequences of interest into host cells with high efficiency. This results in protein production methods with higher yield (mg/L) and a reduction in manufacturing costs that could be used in a range of applications including for example, the production of therapeutic proteins, vaccines and antibodies.
Public/Granted literature
- US20120258494A1 Retroviral Vector Particles and Methods for their Generation and Use Public/Granted day:2012-10-11
Information query
IPC分类: